as of —
₹—
Change
—
Day Open
₹—
Day High
₹—
Day Low
₹—
NSE Close — 25 Sep 2026
₹1,014.0
Change
-32.0 (-3.06%)
Open
₹1,050.0
Prev. Close
₹1,046.0
Day High
₹1,052.0
Day Low
₹1,008.0
Volume Analysis
Traded
1,900,715
Delivered
1,090,852
Delivery %
57.39%
End-of-day NSE price via the official Bhavcopy — updated once daily after market close, not a live tick.
Strengths, Weaknesses, Opportunities & Threats
Strengths (1)
- •Strong operating margin (27.0%)
Weaknesses (0)
No signal for this stock
Opportunities (1)
- •Strong 3-year revenue growth (22.4%)
Threats (1)
- •FII holding has been falling
Rule-based signals from the fundamentals below — not investment advice.
Pivot Levels
| Type | R3 | R2 | R1 | Pivot | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | ₹1,085.34 | ₹1,068.67 | ₹1,041.34 | ₹1,024.67 | ₹997.34 | ₹980.67 | ₹953.34 |
| Fibonacci | ₹1,068.67 | ₹1,051.86 | ₹1,041.48 | ₹1,024.67 | ₹1,007.86 | ₹997.48 | ₹980.67 |
| Camarilla | ₹1,026.1 | ₹1,022.07 | ₹1,018.03 | ₹1,024.67 | ₹1,009.97 | ₹1,005.93 | ₹1,001.9 |
Support/resistance levels for today, calculated from the previous trading day's high/low/close.
Absolute Returns
YTD
-3.37%
1 Week
-4.93%
1 Month
-0.01%
3 Months
-10.21%
6 Months
+5.75%
1 Year
-9.74%
2Y/3Y/5Y not shown yet — price history tracking only goes back to mid-2025 so far.
Stock Vitals
Computed from the latest available annual financials.
Graham Number
₹191.52
Current price is above the Graham Number — Benjamin Graham's estimate of fair value based on earnings and book value.
DuPont ROE Breakdown
13.11%
Net margin 16.72% × asset turnover 0.49x × equity multiplier 1.6x
Company Overview
Sector
Healthcare
Market Cap
₹98,694 Cr
P/E (TTM)
65.9
ROE
14.7%
Book Value
₹110.0
Face Value
₹10.0
Source: Screener.in (Consolidated figures) — data as of 26 Sep 2026. Not investment advice.
TopFund Analysis
Max Healthcare Ins Ltd holds up reasonably well on TopFund's composite fundamentals check within the Healthcare sector, at 68/100. The strongest factor is Financial Strength (99/100), while Valuation (0/100) is the weakest area to weigh before deciding. Notably: Strong operating margin (27.0%). FII holding has been falling.
TopFund Score — Fundamentals Quality
68/100 — GoodData confidence: 78/100 (Moderate Confidence) — based on how complete and how fresh the underlying data is.
As of 27 Sep 2026 · How we calculate this →
Financial Strength
Growth
Valuation
Cash Flow
Corporate Governance
Momentum
Institutional Ownership
Business Quality
Risk & Volatility
Liquidity
From Screener.in
- −Stock is trading at 9.18 times its book value
- −Tax rate seems low
- −Company has a low return on equity of 13.7% over last 3 years.
- −Company might be capitalizing the interest cost
Not investment advice — an automated read of public fundamentals data, for research context only.
Corporate Actions
Postal ballot seeks approval for PRSU scheme, CMD remuneration, and memorandum object-clause changes.
Niche99 assigned Max Healthcare an ESG score of 72, in the Leader category.
Source: BSE regulatory filings, via Screener.in.
Quarterly Results
Last several quarters
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales + | 1,285 | 1,363 | 1,335 | 1,423 | 1,543 | 1,707 | 1,868 | 1,910 | 2,028 | 2,135 | 2,068 | 2,143 | 2,366 |
| Expenses + | 948 | 976 | 949 | 1,041 | 1,156 | 1,257 | 1,369 | 1,398 | 1,505 | 1,560 | 1,529 | 1,536 | 1,768 |
| Operating Profit | 337 | 387 | 386 | 382 | 387 | 451 | 499 | 512 | 523 | 575 | 538 | 606 | 598 |
| OPM % | 26.0% | 28.0% | 29.0% | 27.0% | 25.0% | 26.0% | 27.0% | 27.0% | 26.0% | 27.0% | 26.0% | 28.0% | 25.0% |
| Other Income + | 41 | 45 | 46 | 45 | 35 | 41 | -40 | 47 | 37 | 33 | -3 | 48 | 41 |
| Interest | 19 | 9 | 11 | 21 | 24 | 34 | 52 | 55 | 55 | 54 | 60 | 67 | 71 |
| Depreciation | 56 | 58 | 61 | 70 | 77 | 84 | 98 | 101 | 104 | 108 | 111 | 123 | 132 |
| Profit before tax | 303 | 366 | 360 | 336 | 321 | 374 | 309 | 402 | 400 | 446 | 365 | 465 | 436 |
| Tax % | 21.0% | 24.0% | 20.0% | 25.0% | 26.0% | 25.0% | 23.0% | 21.0% | 23.0% | -10.0% | 17.0% | 26.0% | 26.0% |
| Net Profit + | 240 | 277 | 289 | 252 | 236 | 282 | 239 | 319 | 308 | 491 | 301 | 342 | 323 |
| EPS in Rs | 2 | 3 | 3 | 3 | 2 | 3 | 2 | 3 | 3 | 5 | 3 | 4 | 3 |
| Raw PDF | — | — | — | — | — | — | — | — | — | — | — | — | — |
Source: Screener.in — figures in ₹ Crores unless marked %.
Profit & Loss (Yearly)
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales + | 1,608 | 1,729 | 1,691 | 1,059 | 2,508 | 3,937 | 4,563 | 5,406 | 7,028 | 8,373 | 8,712 |
| Expenses + | 1,467 | 1,616 | 1,535 | 965 | 2,101 | 2,986 | 3,322 | 3,913 | 5,180 | 6,131 | 6,394 |
| Operating Profit | 141 | 113 | 156 | 94 | 407 | 951 | 1,241 | 1,493 | 1,849 | 2,243 | 2,318 |
| OPM % | 9.0% | 7.0% | 9.0% | 9.0% | 16.0% | 24.0% | 27.0% | 28.0% | 26.0% | 27.0% | 27.0% |
| Other Income + | 59 | 65 | 56 | 48 | -122 | 110 | 139 | 177 | 82 | 114 | 118 |
| Interest | 100 | 99 | 101 | 83 | 179 | 101 | 84 | 60 | 165 | 235 | 251 |
| Depreciation | 96 | 94 | 103 | 46 | 174 | 221 | 232 | 245 | 359 | 447 | 474 |
| Profit before tax | 5 | -15 | 8 | 13 | -69 | 739 | 1,064 | 1,365 | 1,406 | 1,676 | 1,711 |
| Tax % | -236.0% | 65.0% | 102.0% | -1.0% | 67.0% | 18.0% | -4.0% | 23.0% | 24.0% | 14.0% | — |
| Net Profit + | 16 | -25 | 0 | 59 | -138 | 605 | 1,104 | 1,058 | 1,076 | 1,442 | 1,457 |
| EPS in Rs | 0 | 0 | 0 | 1 | -1 | 6 | 11 | 11 | 11 | 15 | 15 |
| Dividend Payout % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 9.0% | 14.0% | 14.0% | 13.0% | — |
Source: Screener.in — figures in ₹ Crores unless marked %.
Balance Sheet
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Reserves | 655 | 627 | 426 | 2,016 | 4,673 | 5,313 | 6,439 | 7,436 | 8,409 | 9,774 |
| Borrowings + | 874 | 981 | 1,003 | 875 | 1,101 | 913 | 689 | 1,299 | 3,010 | 3,478 |
| Other Liabilities + | 1,080 | 1,157 | 1,389 | 546 | 1,803 | 1,993 | 2,003 | 2,293 | 2,795 | 2,959 |
| Total Liabilities | 3,146 | 3,302 | 3,355 | 3,974 | 8,543 | 9,189 | 10,102 | 12,000 | 15,186 | 17,184 |
| Fixed Assets + | 2,244 | 2,227 | 2,192 | 851 | 6,536 | 7,018 | 7,039 | 8,784 | 11,502 | 12,991 |
| CWIP | 46 | 38 | 87 | 28 | 27 | 151 | 252 | 553 | 901 | 593 |
| Investments | 0 | 0 | 1 | 2,182 | 1 | 1 | 1 | 2 | 3 | 5 |
| Other Assets + | 856 | 1,036 | 1,075 | 913 | 1,980 | 2,020 | 2,810 | 2,661 | 2,781 | 3,595 |
| Total Assets | 3,146 | 3,302 | 3,355 | 3,974 | 8,543 | 9,189 | 10,102 | 12,000 | 15,186 | 17,184 |
| Equity Capital | 537 | 537 | 537 | 537 | 966 | 970 | 971 | 972 | 972 | 973 |
Source: Screener.in — figures in ₹ Crores unless marked %.
Cash Flow
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operating Activity + | 156 | 166 | 89 | 77 | 118 | 741 | 1,209 | 1,122 | 1,438 | 1,633 |
| Cash from Investing Activity + | -104 | -124 | -17 | -2,641 | 206 | -764 | -1,187 | -1,253 | -1,593 | -1,688 |
| Cash from Financing Activity + | -48 | -48 | -74 | 2,353 | 191 | -294 | -289 | -264 | -163 | 59 |
| Net Cash Flow | 4 | -6 | -2 | -210 | 516 | -317 | -266 | -395 | -318 | 4 |
| CFO/OP | 135 | 166 | 75 | 89 | 15 | 89 | 110 | 93 | 95 | 89 |
| Free Cash Flow | 41 | 100 | -27 | -13 | 1 | 192 | 877 | 342 | 500 | 165 |
Source: Screener.in — figures in ₹ Crores unless marked %.
Shareholding Pattern
Quarter-by-quarter — Promoters, FII, DII & public holding trend
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Public | 4.45% | 3.99% | 3.97% | 3.91% | 3.84% | 3.77% | 3.94% | 4.09% | 4.43% | 4.52% | 4.58% | 4.55% |
| Promoters | 23.76% | 23.75% | 23.75% | 23.74% | 23.74% | 23.74% | 23.74% | 23.74% | 23.74% | 23.72% | 23.71% | 23.71% |
| FII | 60.39% | 60.69% | 57.33% | 56.99% | 57.29% | 56.93% | 54.74% | 54.76% | 51.8% | 50.55% | 45.39% | 41.78% |
| DII | 11.4% | 11.55% | 14.96% | 15.36% | 15.14% | 15.55% | 17.59% | 17.41% | 20.03% | 21.2% | 26.32% | 29.95% |
Source: Screener.in — quarterly shareholding disclosures.
Peers Comparison
Healthcare — ranked by market cap
| Company | Market Cap (Cr) | P/E | P/B | ROE |
|---|---|---|---|---|
| Max Healthcare Ins Ltd (this stock) | 98,694 | 65.9 | 9.22 | 14.7% |
| Aurobindo Pharma Ltd | 98,939 | 26.2 | 2.64 | 10.1% |
| Manipal Health Enterpri L | 98,193 | 111.0 | — | 12.7% |
| Dr. Reddy S Laboratories | 101,096 | 31.4 | 2.67 | 11.2% |
| Lupin Limited | 95,788 | 16.1 | 4.26 | 28.7% |
| Mankind Pharma Limited | 102,225 | 47.9 | 6.27 | 13.1% |
| Laurus Labs Limited | 108,438 | 99.2 | 20.44 | 18.3% |
Which Mutual Funds Hold Max Healthcare Ins Ltd?
Frequently Asked Questions about Max Healthcare Ins Ltd
Max Healthcare Ins Ltd (MAXHEALTH) closed at ₹1,014.0 on NSE on 25 September 2026, down 32.0 (3.06%) from the previous close.
Max Healthcare Ins Ltd trades on the NSE (National Stock Exchange of India) under the symbol MAXHEALTH.
Max Healthcare Ins Ltd has a trailing twelve-month P/E (price-to-earnings) ratio of 65.9.
Max Healthcare Ins Ltd has a dividend yield of 0.2%.
Max Healthcare Ins Ltd's 52-week high is ₹1,222.0 and its 52-week low is ₹903.0.
Max Healthcare Ins Ltd has a market capitalisation of ₹98,694 crore.
Max Healthcare Ins Ltd has a TopFund Quality Score of 68/100 (Good), a composite of profitability, balance-sheet health, growth and valuation. This is an analytical score based on public data, not personalized investment advice — see the full breakdown below before deciding.
Community Sentiment
What are other investors saying about Max Healthcare Ins Ltd?
No votes yet — be the first to share your view.
Sign in to voteDiscussion
User-generated content — not investment advice, and not verified or endorsed by TopFund.
Sign in to join the discussionNo comments yet — start the discussion.